Drug Profile
Zanapezil
Alternative Names: TAK 147Latest Information Update: 20 Jun 2003
Price :
$50
*
At a glance
- Originator Takeda
- Class Neuroprotectants; Nootropics
- Mechanism of Action Acetylcholinesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 20 Jun 2003 Discontinued - Phase-III for Alzheimer's disease in Japan (PO)
- 19 Sep 2002 This compound is still in active development
- 01 Nov 1999 Phase-III clinical trials for Alzheimer's disease in Japan (PO)